Detalles de la búsqueda
1.
Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study.
Jpn J Clin Oncol
; 51(3): 345-353, 2021 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33619550
2.
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
Cancer
; 126 Suppl 16: 3867-3882, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710660
3.
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1.
Breast Cancer Res
; 19(1): 47, 2017 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28399902
4.
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
Lancet Oncol
; 16(7): 816-29, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26092818
5.
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 16(4): 436-46, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25795409
6.
Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center.
Chin J Cancer
; 33(10): 492-500, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25104281
7.
Efficacy and safety of inetetamab in combination with chemotherapy as first-line treatment of HER2-positive metastatic breast cancer: a subgroup analysis in the HOPES study.
Transl Breast Cancer Res
; 3: 15, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-38751509
8.
Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients.
Chin J Cancer
; 30(5): 327-35, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21527065
9.
Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.
Chin J Cancer
; 29(4): 413-9, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20346218
10.
Development and validation of a nomogram in survival prediction among advanced breast cancer patients.
Ann Transl Med
; 8(21): 1446, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33313191
11.
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
Zhonghua Zhong Liu Za Zhi
; 29(1): 58-61, 2007 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-17575697
12.
[A survival of 103 cases of T-cell non-Hodgkin lymphoma].
Zhonghua Nei Ke Za Zhi
; 46(12): 1000-2, 2007 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-18478916
13.
Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study.
Oncotarget
; 7(31): 50643-50655, 2016 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27276706
14.
Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China.
Arch Med Sci
; 11(3): 544-50, 2015 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26170847
15.
National consensus in China on diagnosis and treatment of patients with advanced breast cancer.
Ann Transl Med
; 3(17): 242, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26605288
16.
[First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer].
Zhonghua Zhong Liu Za Zhi
; 26(2): 119-21, 2004 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-15059335
17.
HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients.
Onco Targets Ther
; 6: 341-7, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23630425
18.
Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancer.
Med Oncol
; 29(1): 39-47, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21302001
19.
Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer.
J Cancer Res Clin Oncol
; 138(4): 705-14, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22237454
20.
[Neuroendocrine tumors of the kidney: report of 3 cases and review of the literature].
Nan Fang Yi Ke Da Xue Xue Bao
; 31(3): 548-50, 2011 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-21421504